Quantcast
Last updated on April 16, 2014 at 12:22 EDT

Latest Toceranib Stories

83dac85655e26735e11b0253cdeb5d391
2009-06-03 14:35:00

The US Food and Drug Administration has approved Pfizer Inc's Palladia, a cancer treatment drug designed for dogs. The announcement on Wednesday makes Palladia the first FDA-approved cancer therapy for dogs. Previous attempts at fighting cancer in dogs relied on drugs designed for humans, said Bernadette Dunham, director of FDA's Center for Veterinary Medicine. "This cancer drug approval for dogs is an important step forward for veterinary medicine," Dunham said in a statement. "Today's...

c2af5f13b937287a2ce5d7e8b6b2f15b1
2009-06-03 09:32:53

The U.S. Food and Drug Administration has approved the first drug developed specifically for the treatment of cancer in dogs. The FDA said Palladia (toceranib phosphate) has been approved to treat canine cutaneous mast cell tumors, a type of cancer responsible for about 1 of 5 cases of canine skin tumors. All cancer drugs currently used in veterinary medicine originally were developed for use in humans and are not approved for use in animals, the federal agency said. Cancer treatments used in...

2008-09-11 09:00:48

According to a new study by Cutting Edge Information, tyrosine kinase inhibitors may have five oncology drugs with annual sales over $1 billion by 2013. This list of blockbuster oncology drugs includes Novartis' Gleevec. Annual sales of Gleevec are projected to steadily grow to $4.6 billion dollars in 2012, making it a top five oncology drug. There are four other approved tyrosine kinase inhibitors that are estimated to surpass $1 billion in annual sales by 2013, one of which is Pfizer's...